title: [Consensus for the study and treatment of Fabry disease. GETER Foundation].
authors.affiliation: Servicio de Medicina Intensiva, Hospital Universitario La Paz, Madrid, España. agdl@telefonica.net
authors.forename: Abelardo
authors.initials: A
authors.lastname: García de Lorenzo
mesh_terms: D000293:Adolescent; D000328:Adult; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002648:Child; D000075202:Contraindications; D057210:Delayed Diagnosis; D003937:Diagnosis, Differential; D019468:Disease Management; D056947:Enzyme Replacement Therapy; D000795:Fabry Disease / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000628:therapy*; D005260:Female; D006331:Heart Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007962:Leukocytes / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D009437:Neuralgia / Q000188:drug therapy / Q000209:etiology; D017582:Renal Replacement Therapy; D000519:alpha-Galactosidase / Q000097:blood / Q000235:genetics / Q000627:therapeutic use
chemical_list: D002317:Cardiovascular Agents; D000519:alpha-Galactosidase